Roche to acquire Carmot Therapeutics for $3.1B, gaining access to innovative obesity and diabetes treatments. The deal includes clinical-stage assets with potential for standalone and combination therapies. Expected to close in Q1 2024, pending regulatory approval.
Samsung Biologics & Kurma Partners team up for biologics development & manufacturing, empowering startups in Kurma's portfolio with tailored CMC services & global expertise. A strategic partnership driving biopharmaceutical innovation.
Edesa Biotech secures C$23 million in government funding for Phase 3 clinical study of EB05, a pioneering immune therapy, as announced in their press release. The funding reinforces their commitment to advancing healthcare innovation.
Pfizer-backed VitaDAO marks a milestone, launching Matrix Biosciences, their first longevity-focused biotech company, aiming to unlock breakthroughs in extending human life. Dr. Vera Gorbunova leads the venture, exploring the secrets of cancer-resistant naked mole-rats.
The 2023 Nobel Prize in Physiology or Medicine has been awarded to Dr. Katalin Karikó and Dr. Drew Weissman for their groundbreaking work in the development of mRNA-based COVID-19 vaccines.